Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Ischemic stroke: cumulative recurrence rates
3. Reducing recurrent stroke risk: lifestyle changes
4. Secondary prevention
5. Platelet antiaggregants
6. Aspirin for TIA and stroke
7. Clopidogrel - CAPRIE trial
8. CAPRIE trial: primary analysis
9. CAPRIE trial: outcome by disease strata
10. MATCH trial: study design
11. MATCH trial: results
12. CHARISMA trial
13. CHARISMA trial: results
14. Aspirin-sustained release dipyridamole (ESPS-2)
15. ESPRIT trial
16. ESPRIT trial: results
17. Secondary prevention: anticoagulants
18. Atrial fibrillation: warfarin vs. antiplatelet drugs
19. Atrial fibrillation: stroke risk stratification
20. Warfarin aspirin recurrent stroke study (WARSS)
21. WARSS trial: results
22. WASID trial
23. WASID trial: results
24. Secondary prevention: blood pressure
25. Antihypertensives- secondary prevention (UK-TIA)
26. BP treatment and stroke risk
27. PROGRESS trial
28. PROGRESS trial: results
29. Secondary prevention: lipid lowering
30. Statins for prevention of CVD and stroke
31. Heart protection study
32. HPS results: patients with vs. without prior stroke
33. SPARCL: study design
34. SPARCL results: primary endpoint
35. SPARCL results: secondary endpoints
36. SPARCL: NNT to prevent one event over 5 years
37. Safety
38. Post-hoc analyses: cerebrovascular endpoints
39. Post-hoc analysis: ischemic \ hemorrhagic stroke
40. Multivariable Cox regression model (1)
41. Multivariable Cox regression model (2)
42. Outcome by entry event: fatal or non-fatal stroke
43. Summary

Topics Covered

• Risk of recurrent stroke
• Lifestyle modification
• Platelet antiaggregant therapy; aspirin, clopidogrel, aspirin plus sustained-release dypiridamole
• Antihypertensive therapy
• Lipid lowering therapy

Links

Series:

• Cerebrovascular Disease

Categories:

• Clinical Practice
• Neuroscience

Therapeutic Areas:

• Neurology

Talk Citation

Goldstein, L. (2008, October 27). Medical therapy for secondary prevention of ischemic stroke [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/WJPO8900.
Export Citation (RIS)

Publication History

• Published on October 27, 2008
• Archived on December 10, 2018

Financial Disclosures

• Prof. Larry Goldstein has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.